S. 1421 - Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
- Sponsor:
- Orrin G. Hatch
- Summary:
- A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize a 6-month extension of certain exclusivity periods in the case of approved drugs that are subsequently approved for a new indication to prevent, diagnose, or treat a rare disease or condition, and for other purposes. (by CRS)
- Status:
- The bill has been referred to committee.
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
S. 1421 — 114th Congress (2015–2016)
- Summary
- A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize a 6-month extension of certain exclusivity periods in the case of approved drugs that are subsequently approved for a new indication to prevent, diagnose, or treat a rare disease or condition, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize a 6-month extension of certain exclusivity periods in the case of approved drugs that are subsequently approved for a new indication to prevent, diagnose, or treat a rare disease or condition, and for other purposes.
- Other Titles
- Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
- Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
- Sponsor
- Orrin G. Hatch
- Co-Sponsors
- Subjects
- Health
- Administrative remedies
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Food and Drug Administration (FDA)
- Government information and archives
- Intellectual property
- Prescription drugs
- Related Bills
- Major Actions
Introduced 5/21/2015 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 5/21/2015 5/21/2015 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. 5/21/2015 Introduced in Senate Number Sponsor Date Offered Status
Average contributions given to Senators from interest groups that…
supported this bill
Non-profit foundations |
Health, Education & Human Resources |
Children's rights |
Health & welfare policy |
Contributions data source: OpenSecrets.org